Merger Pending

Proposed Ignite Proteomics Inc. holding company and Ignite Proteomics merger

US$150m equity value

Announced 9 Jun 2026

Advisers

Ignite Proteomics

Target

Not disclosed

Proposed Ignite Proteomics Inc. holding company

Acquirer

Not disclosed

Other advisers

Financial adviser
Legal adviser
Meister Seelig & Schuster PLLC
Target
Ignite Proteomics
Acquirer
Proposed Ignite Proteomics Inc. holding company
Seller
Aditxt
Target based in
United States (unverified)
Buyer based in
United States (unverified)
Seller based in
United States
Sector
Life Sciences
Tags
Life Sciences, Diagnostics, Oncology

In the league tables

Similar deals

All life sciences deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.